Bode John B 4
4 · ZEVRA THERAPEUTICS, INC. · Filed May 19, 2023
Insider Transaction Report
Form 4
Bode John B
Director
Transactions
- Purchase
Common Stock
2023-05-18$5.05/sh+2,451$12,378→ 10,000 total - Purchase
Common Stock
2023-05-18$5.04/sh+1,390$6,999→ 1,390 total - Purchase
Common Stock
2023-05-18$5.04/sh+300$1,512→ 1,690 total - Purchase
Common Stock
2023-05-18$5.04/sh+1,000$5,040→ 2,690 total - Purchase
Common Stock
2023-05-18$5.04/sh+100$505→ 7,549 total - Purchase
Common Stock
2023-05-18$5.04/sh+4,759$23,985→ 7,449 total